# OnCo record lung-cancer-evidence-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/lung-cancer-evidence-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "lung-cancer-evidence-roadmap" ;
  schema:name "Lung cancer roadmap: from Doll and Hill and the naming of tobacco, through the cytotoxic plateau, computed tomography screening, EGFR and ALK, immunotherapy by PD-L1, the perioperative trials and PACIFIC, to DLL3 in small-cell disease and a 2032 registry watch"@en ;
  schema:alternateName "Lung cancer history"@en, "Lung cancer evidence roadmap"@en, "NSCLC and SCLC roadmap"@en, "Thoracic oncology roadmap"@en ;
  schema:description "Lung cancer is where modern cancer epidemiology began: two studies in 1950 tied it to cigarettes, and a fifty-year cohort proved it. This roadmap follows the evidence from there through chemotherapy that barely worked, the scans that find the disease early, the drugs for cancers that depend on one broken gene, immunotherapy, and small-cell disease, to 2032."@en ;
  schema:url <https://onco.cc/roadmaps/lung-cancer-evidence-roadmap/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://www.cancer.gov/types/lung>, <https://www.esmo.org/guidelines/esmo-clinical-practice-guidelines-lung-and-chest-tumours>, <https://www.iaslc.org/>, <https://clinicaltrials.gov/study/NCT01888601> ;
  onco:status "active" ;
  onco:related <https://onco.cc/roadmaps/prevention-roadmap/>, <https://onco.cc/roadmaps/early-detection-roadmap/>, <https://onco.cc/roadmaps/targeted-therapy-roadmap/>, <https://onco.cc/roadmaps/immunotherapy-roadmap/>, <https://onco.cc/roadmaps/radiation-roadmap/>, <https://onco.cc/roadmaps/chemotherapy-roadmap/>, <https://onco.cc/roadmaps/kras-roadmap/>, <https://onco.cc/roadmaps/ctdna-tests/>, <https://onco.cc/roadmaps/diagnostics-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:sections <https://onco.cc/fronts/prevention/>, <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/surgery/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-resistance/>, <https://onco.cc/bottlenecks/b-immunotherapy-response/>, <https://onco.cc/bottlenecks/b-brain-delivery/>, <https://onco.cc/bottlenecks/b-tumor-heterogeneity/>, <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-biomarker-validation/> .